Two new Neutrogena facial sunscreens incorporate bemotrizinol, the first new sunscreen active ingredient added to the US OTC monograph in decades.
News|Articles|January 2, 2026
Dermatology Times' 2026 Health Awareness Calendar of Dates
Author(s)Marie Bosslett, Assistant Editor
Listen
0:00 / 0:00
Key Takeaways
- Dermatology Times will provide updates, interviews, studies, and resources for dermatology-related awareness events in 2026 to improve patient care.
- Readers are encouraged to share any missed dermatologic awareness initiatives via social media or email.
Discover essential dermatology awareness dates and initiatives for 2026, as we enhance patient care with updates, interviews, and resources throughout the year.
Advertisement
As we kick off the new year, Dermatology Times has put together a comprehensive list of dermatology-related health awareness days, months, weeks, and initiatives for 2026. Throughout the year, we will provide the latest updates, interviews, studies, and resources to commemorate these awareness initiatives, all in the name of improving patient care.
Spot any dermatologic awareness initiatives we may have missed in our roundup? Share with us by contacting us on social media or emailing our team at
January
- January 8: National Winter Skin Relief Day
February
- National Cancer Prevention Month
- American Heart Month
- February 4: World Cancer Day
- February 28: Rare Disease Day
March
- Women's History Month
- March 8: International Women's Day
- March 12: National Skin Barrier Day
- March 13: National Dermatologist Day
- March 30: National Doctors' Day
- March 31: Transgender Day of Visibility
April
- Rosacea Awareness Month
- Stress Awareness Month
- April 2: World Autism Day
- April 22: Earth Day
May
- Psoriatic Arthritis Action Month
- Skin Cancer Awareness & Prevention Month
- Mental Health Awareness Month
- May 4: Melanoma Monday
- May 24: Actinic Keratoses (AK) Global Day
- May 31: Necrotizing Fasciitis Awareness Day
June
- Acne Awareness Month
- Vitiligo Awareness Month
- Scleroderma Awareness Month
- June 1-7: Hidradenitis Suppurativa (HS) Awareness Week
- June 13: International Albinism Awareness Day
- June 25: World Vitiligo Day
- June 28: National Climate-Smart Skin Awareness Day
- June 29: World Scleroderma Day
July
- UV Safety Month
- Hyperpigmentation & Melasma Awareness Month
- July 8: World Skin Health Day
August
- Psoriasis Awareness & Action Month
- Hair Loss Awareness Month
- August 13: Generalized Pustular Psoriasis (GPP) Awareness Day
September
- Alopecia Awareness Month
- Skin Care Awareness Month
- September 13-19: National Eczema Week
- September 14: World Atopic Eczema Day
- September 20-26: National Advanced Practice Provider (APP) Week
October
- Eczema Awareness Month
- October 1: World Urticaria Day (UDAY)
- October 1-7: Body-Focused Repetitive Behaviors (BFRBs) Awareness Week
- October 6-12: National Physician Assistant/Associate (PA) Week
- October 19: Psoriatic Arthritis Awareness Day
- October 29: World Psoriasis Day
November
- Hyperhidrosis Awareness Month
- National Healthy Skin Month
- November 8-14: National Nurse Practitioner (NP) Week
- November 20: BOTOX Cosmetic (OnabotulinumtoxinA) Day
December
Advertisement
Related to this article
From emerging therapies to earlier intervention and psychosocial support, Dermatology Times looks back at key alopecia areata developments in 2026.
Put your dermatology expertise to the test with Dermatology Times’ interactive quiz series.
Can at-home dermarollers give the same results as in-office microneedling or is that just a myth? Read more about the latest social media trend and learn how to counsel your patients in the clinic.
The FDA approval, based on 36-week data from the phase 3 BRAVE-AA-PEDS trial, extends baricitinib access to patients as young as 12 years old with severe alopecia areata.
Guselkumab met primary and major secondary endpoints in the phase 4 STAR study, improving axial PsA symptoms and MRI-confirmed inflammation.
Find out what skin care products and aesthetic innovations clinicians are recommending to patients for the month of September.
Three experimental hair loss mechanisms are moving through late-stage trials for the first time in decades, and the data are worth knowing before patients ask.
Advertisement
Advertisement
Trending on Dermatology Times
1
FDA Approves Baricitinib for Adolescents With Severe Alopecia Areata
2
Tremfya Meets Primary, Major Secondary Endpoints in Phase 4 STAR Study of Axial PsA
3
From Mechanism to Management: Navigating Male Pattern Hair Loss and New Topical Therapies
4
FAQ: Everything Clinicians (and Their Patients) Want to Know About the Hair Loss Pipeline
5